Siga Technologies (SIGA) Equity Income (2010 - 2015)

Siga Technologies' (SIGA) quarterly Equity Income came in at $313425.0 in Q4 2015, up 270.31% on a QoQ basis from -$184027.0 in Q3 2015.

Siga Technologies (SIGA) Equity Income (2010 - 2015) Analysis & Trends

Siga Technologies (SIGA) has 6 years of Equity Income data on file, last reported at $313425.0 in Q4 2015.

Quarterly Equity Income changed N/A year-over-year to $313425.0 in Q4 2015, while the trailing twelve-month figure through Sep 2015 was -$313425.0 (up 72.53% YoY) and the FY2014 annual result came in at -$313425.0, down 524.95% from the prior year.
Equity Income improved to $313425.0 in Q4 2015, from -$184027.0 in the prior quarter.
In the past five years, Equity Income ranged from a high of $999529.0 in Q1 2012 to a low of -$12.8 million in Q3 2011.
A 5-year average of -$1.4 million and a median of -$184027.0 in 2014 frame the typical range for Equity Income.
Annual changes were most pronounced in 2011 — Equity Income sank 736.16% — and 2013, when it jumped 451.04%.
Tracing SIGA's Equity Income over 5 years: stood at -$1.1 million in 2011, then grew by 5.95% to -$1.0 million in 2012, then jumped by 36.56% to -$655109.0 in 2013, then soared by 71.91% to -$184027.0 in 2014, then surged by 270.31% to $313425.0 in 2015.
The last three Equity Income figures came in at $313425.0 (Q4 2015), -$184027.0 (Q3 2015), and -$129398.0 (Q2 2015), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Income (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-	-
2	Teva Pharmaceutical Industries	43.28 Bn	39.62 Bn	2.15 Bn	-500,000.00
3	Zoetis	31.78 Bn	30.11 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.71 Bn	22.91 Bn	5.10 Bn	3.38 Mn
5	United Therapeutics	22.25 Bn	19.59 Bn	683.80 Mn	-
6	Viatris	18.72 Bn	17.83 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.57 Bn	15.18 Bn	935.80 Mn	-
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.14 Bn	9.97 Bn	-	-
10	Siga Technologies	213.02 Mn	58.06 Mn	-	-

Download Data